参考文献/References:
[1] Towbin JA,Lorts A,Jefferies JL. Left ventricular non-compaction cardiomyopathy[J]. Lancet,2015,386(9995):813-825.
[2] Ivanov A,Dabiesingh DS,Bhumireddy GP,et al. Prevalence and prognostic significance of left ventricular noncompaction in patients referred for cardiac magnetic resonance imaging[J].Circ Cardiovasc Imaging,2017,10(9):e006174.
[3] Ross SB,Jones K,Blanch B,et al. A systematic review and meta-analysis of the prevalence of left ventricular non-compaction in adults[J].Eur Heart J,2020,41(14):1428-1436.
[4] Cardoso B,Jeewa A,Minn S,et al. Left ventricular non-compaction cardiomyopathy - left ventricular dilation and dysfunction at baseline portend the risk of death or heart transplantation[J].Can J Cardiol,2022,38(6):754-762.
[5] Cerar A,Jaklic M,Frljak S,et al. Impairment of myocardial perfusion correlates with heart failure severity in patients with non-compaction cardiomyopathy[J]. ESC Heart Fail,2020,7(3):1161-1167.
[6] Capulzini L,Sorgente A. Ventricular fibrillation undersensing in a patient with left ventricular non-compaction cardiomyopathy and a cardiac resynchronization therapy implantable defibrillator (CRT-D)[J].J Interv Card Electrophysiol,2021,60(3):559-560.
[7] de Zio R,Pietrafesa G,Milano S,et al. Role of nuclear lamin A/C in the regulation of Nav1.5 channel and microtubules:lesson from the pathogenic lamin A/C variant Q517X[J]. Front Cell Dev Biol,2022,10:918760.
[8] Miyake CY,Kim JJ. Arrhythmias in left ventricular noncompaction[J]. Card Electrophysiol Clin,2015,7(2):319-330.
[9] Rao K,Bhaskaran A,Choudhary P,et al. The role of multimodality imaging in the diagnosis of left ventricular noncompaction[J].Eur J Clin Invest,2020,50(9):e13254.
[10] Xu L,Yang J,Yang Y. Acute kidney infarction due to left ventricular thrombus embolization in patient with isolated left ventricular noncompaction:a case report[J]. Heart Surg Forum,2017,20(6):E252-E255.
[11] Adabifirouzjaei F,Igata S,DeMaria AN. Hypertrabeculation; a phenotype with Heterogeneous etiology[J].Prog Cardiovasc Dis,2021,68:60-69.
[12] Srivastava S,Yavari M,Al-Abcha A,et al. Ventricular non-compaction review[J]. Heart Fail Rev,2022,27(4):1063-1076.
[13] D’Amato G,Luxán G, Monte-Nieto G ,et al. Sequential Notch activation regulates ventricular chamber development[J]. Nat Cell Biol,2016,18(1):7-20.
[14] D’Amato G,Luxán G,de la Pompa JL. Notch signalling in ventricular chamber development and cardiomyopathy[J]. FEBS J,2016,283(23):4223-4237.
[15] Wald R,Veldtman G,Golding F,et al. Determinants of outcome in isolated ventricular noncompaction in childhood[J].Am J Cardiol,2004,94(12):1581-1584.
[16] Kodo K,Ong SG,Jahanbani F,et al. iPSC-derived cardiomyocytes reveal abnormal TGF-β signalling in left ventricular non-compaction cardiomyopathy[J]. Nat Cell Biol,2016,18(10):1031-1042. Left ventricular noncompaction:from physiologic remodeling to noncompaction?cardiomyopathy
[17] van Waning JI,Caliskan K,Hoedemaekers YM,et al. Genetics,clinical features,and long-term?outcome of noncompaction?cardiomyopathy[J]. J Am Coll Cardiol,2018,71(7):711-722.
[18] Oechslin E,Jenni R. Left Ventricular Noncompaction:From Physiologic Remodeling to Noncompaction?Cardiomyopathy[J]. Journal of the American College of Cardiology,2018,71(7):723-726.
[19] Aung N,Doimo S,Ricci F,et al. Prognostic significance of left ventricular noncompaction:systematic review and meta-analysis of observational studies[J]. Circ Cardiovasc Imaging,2020,13(1):e009712.
[20] Gati S,Papadakis M,van Niekerk N,et al. Increased left ventricular trabeculation in individuals with sickle cell anaemia:physiology or pathology?[J]. Int J Cardiol,2013,168(2):1658-1660.
[21] Zemrak F,Ahlman MA,Captur G,et al. The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5-year follow-up:the MESA study[J]. J Am Coll Cardiol,2014,64(19):1971-1980.
[22] Weir-McCall JR,Yeap PM,Papagiorcopulo C,et al. Left ventricular noncompaction:anatomical phenotype or distinct cardiomyopathy?[J]. J Am Coll Cardiol,2016,68(20):2157-2165.
[23] Amzulescu MS,Rousseau MF,Ahn SA,et al. Prognostic impact of hypertrabeculation and noncompaction phenotype in dilated?cardiomyopathy:a CMR study[J]. JACC Cardiovasc Imaging,2015,8(8):934-946.
[24] Andreini D,Pontone G,Bogaert J,et al. Long-term prognostic value of cardiac?magnetic resonance in left?ventricle noncompaction:a prospective multicenter study[J]. J Am Coll Cardiol,2016,68(20):2166-2181.
[25] Al-Kindi SG,El-Amm C,Ginwalla M,et al. Heart transplant outcomes in patients with left ventricular non-compaction cardiomyopathy[J]. J Heart Lung Transplant,2015,34(6):761-765.
[26] Balsara KR,Bierhals A,Vader J,et al. Implantation of left ventricular assist device in a patient with left ventricular non-compaction[J]. J Card Surg,2017,32(2):159-161.
[27] McMurray JJ,Packer M,Desai AS,et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure[J].N Engl J Med,2014,371(11):993-1004.
[28] Sohns C,Ouyang F,Volkmer M,et al. Therapy of ventricular arrhythmias in patients suffering from isolated left ventricular non-compaction cardiomyopathy[J]. Europace,2019,21(6):961-969.
[29] 幸奠霞,徐海,徐耀凤,等. 抗凝治疗对心肌致密化不全患者体循环栓塞发病率的影响[J]. 中国老年学杂志,2016,36(21):5281-5283.
[30] Kido K,Guglin M. Anticoagulation therapy in specific cardiomyopathies:isolated left ventricular noncompaction and peripartum cardiomyopathy[J].J Cardiovasc Pharmacol Ther,2019,24(1):31-36.
[31] Tian T,Yang Y,Zhou L,et al. Left ventricular non-compaction:a cardiomyopathy with acceptable prognosis in children[J].Heart Lung Circ,2018,27(1):28-32.
[32] Vaidya VR,Lyle M,Miranda WR,et al. Long-term survival of patients with left ventricular noncompaction[J].J Am Heart Assoc,2021,10(2):e015563.
[33] St?mpfli SF,Erhart L,Hagenbuch N,et al. Prognostic power of NT-proBNP in left ventricular non-compaction cardiomyopathy[J]. Int J Cardiol,2017,236:321-327.
[34] Ramchand J,Podugu P,Obuchowski N,et al. Novel approach to risk stratification in left ventricular non-compaction using a combined cardiac imaging and plasma biomarker approach[J].J Am Heart Assoc,2021,10(8):e019209.
相似文献/References:
[1]唐欣 罗素新.心房颤动合并 射血分数保留的心力衰竭的研究进展[J].心血管病学进展,2019,(5):753.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.022]
TANG Xin,LUO Suxin.Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2019,(4):753.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.022]
[2]黄巧娟 周晓莉.冠状动脉慢血流现象的研究进展[J].心血管病学进展,2020,(2):163.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.016]
HUANG QiaojuanZHOU Xiaoli.Coronary Slow Flow Phenomenon[J].Advances in Cardiovascular Diseases,2020,(4):163.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.016]
[3]朱珊英,朱国斌.肺动脉高压发病机制新进展[J].心血管病学进展,2020,(3):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
ZHU Shanying,ZHU Guobin.Pathogenesis of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2020,(4):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
[4]郭辅定 殷铭 赖燕秋 江洪.蒽环类药物相关心血管疾病与自主神经调控展望[J].心血管病学进展,2021,(3):248.[doi:10.16806/j.cnki.issn.1004-3934.20 21.03.014]
GUO Fuding,YIN Ming,LAI Yanqiu,et al.Anthracycline-induced Cardiovascular Diseases and Autonomic Nervous Regulation[J].Advances in Cardiovascular Diseases,2021,(4):248.[doi:10.16806/j.cnki.issn.1004-3934.20 21.03.014]
[5]韩雅洁 范小倩 巩彩霞 赵子龙 乔成栋.致心律失常性左室心肌病的研究进展[J].心血管病学进展,2021,(4):342.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.013]
HAN Yajie,FAN Xiaoqian,GONG Caixia,et al.Arrhythmogenic Left Ventricular Cardiomyopathy[J].Advances in Cardiovascular Diseases,2021,(4):342.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.013]
[6]韩嘉明 高中山 马玉兰.不适当窦性心动过速的研究进展[J].心血管病学进展,2022,(3):253.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.018]
HAN JiamingGAO ZhongshanMA Yulan.Inappropriate Sinus Tachycardia[J].Advances in Cardiovascular Diseases,2022,(4):253.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.018]
[7]聂琼 吴镜.射血分数保留性心力衰竭：从机制到治疗[J].心血管病学进展,2022,(3):258.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2022.03.0170]
NIE Qiong,WU Jing.Heart Failure with Preserved Ejection Fraction:from Mechanism to Treatment[J].Advances in Cardiovascular Diseases,2022,(4):258.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2022.03.0170]
[8]智慧 赵青 柳志红.慢性血栓栓塞性肺动脉高压发病机制新进展：从基础到临床[J].心血管病学进展,2022,(4):297.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.003]
HUANG Zhihua,LUO Qin,ZHAO Zhihui,et al.Pathogenesis of Chronic Thromboembolic Pulmonary Hypertension:from Bench to Bedside[J].Advances in Cardiovascular Diseases,2022,(4):297.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.003]
[9]丁晓彤 郭俊 王大震 朱胜松 杨斐然 唐闽.肾积水与高血压的研究进展[J].心血管病学进展,2023,(3):212.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.005]
DING Xiaotong,GUO Jun,WANG Dazhen,et al.Hydronephrosis and Hypertension[J].Advances in Cardiovascular Diseases,2023,(4):212.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.005]
[10]雷悦云 邵磊 高传玉 张优.早发冠心病发病机制相关基因多态性研究进展[J].心血管病学进展,2023,(4):331.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.010]
LEI Yueyun,SHAO Lei,GAO Chuanyu,et al.Gene Polymorphisms related to the Pathogenesis of?remature Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2023,(4):331.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.010]